Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Our study is aim to evaluate the efficacy and safety of pabolizumab in neoadjuvant immunotherapy of locally advanced microsatellite-unstable gastric adenocarcinoma.
Epistemonikos ID: 54629bc0876b3ba5e817d393260c90c337d3bc5b
First added on: May 14, 2024